TrialKit AI eClinical Platform

Crucial Data Solutions (CDS) was founded in 2010 and is based in Reno, Nevada, according to its press release and contact address. It develops TrialKit, an eClinical platform for collecting, centralizing and managing clinical data in site-based and decentralized trials.

TrialKit covers EDC and eSource, eCOA/ePRO, eConsent, eTMF, RTSM/IRT, remote patient monitoring and wearables, and televisits. Its proprietary AI model, Floyd, powers TrialKit AI for natural-language reporting, study simulation with virtual participants, validation and statistical analysis. The site claims 60,000+ users and 10,000+ studies.

• EDC and eSource: electronic data capture with direct source data entry.
• eCOA/ePRO and eConsent: patient-reported outcomes and electronic consent.
• Remote monitoring: wearables, remote patient monitoring and televisits.
• TrialKit AI: natural-language reporting and analytics powered by Floyd.
• Study simulation: virtual participants for validation and duration forecasting.
• API integrations: EHR-to-EDC API and connections to health data sources.

Vietnamese university hospitals running investigator-initiated studies could use TrialKit for EDC and ePRO. Biotech startups could simulate study designs before submitting protocols to ethics boards.

Unifies EDC, eCOA, eConsent and supply management in one system. Simulates a study before the first patient to check design and forecast duration. Runs on web, iOS, Android and macOS apps. States alignment with 21 CFR Part 11, GDPR, HIPAA and ICH GCP.

Sponsors and academic groups want unified eClinical platforms that handle decentralized elements and use AI for analysis and study design. Vietnamese research institutes and small biotechs can adopt cloud EDC and eCOA without building their own systems.

Founded 2010 (press release 2026-04). Reno, Nevada. CEO Paul Grady. TrialKit AI won the 2024 SCDM Innovation in Health Technology Solutions Award (per search listing).